Listed

BridgeBio Pharma, Inc.: Form 10-Q for the period ended Jun 30, 2019

Filed with the SEC on Aug 14, 2019 and accepted by EDGAR at Aug 14, 2019, 06:07 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cash and equivalentsAt period end2019-06-30$112.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Shareholders' equityAt period end2019-06-30$0us-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-19-031927. Last ingested by Listed: Nov 12, 2026, 17:56 ET. Listed shows no prices and gives no investment advice.